Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Yap

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2015
Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA TrialCharles Craddock, Nadira Jilani, Shamyla Siddique, et al.
Neuropathology and Applied Neurobiology|April 12, 2024
Adult brain tumour research in 2024: Status, challenges and recommendationsKarin Purshouse, Helen J Bulbeck, Alasdair G Rooney, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Trials|October 5, 2023
Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharingMartin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, et al.
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.
BMC Medicine|August 9, 2022
Practical guidance for planning resources required to support publicly-funded adaptive clinical trialsJames M S Wason, Munyaradzi Dimairo, Katie Biggs, et al.
BMJ Open|November 30, 2017
Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trialRichard W Laing, Hynek Mergental, Christina Yap, et al.
Plos Biology|June 8, 2023
Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasomeBrian V Tsu, Rimjhim Agarwal, Nandan S Gokhale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Addition of dendritic cell vaccination to conditioning cyclophosphamide and chemoembolisation in patients with hepatocellular carcinoma: the ImmunoTACE trialYuk Ting Ma, Jianmin Zuo, Amanda Kirkham, et al.
The Lancet. Oncology|March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2015
Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA TrialCharles Craddock, Nadira Jilani, Shamyla Siddique, et al.
Neuropathology and Applied Neurobiology|April 12, 2024
Adult brain tumour research in 2024: Status, challenges and recommendationsKarin Purshouse, Helen J Bulbeck, Alasdair G Rooney, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Trials|October 5, 2023
Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharingMartin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, et al.
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.
BMC Medicine|August 9, 2022
Practical guidance for planning resources required to support publicly-funded adaptive clinical trialsJames M S Wason, Munyaradzi Dimairo, Katie Biggs, et al.
BMJ Open|November 30, 2017
Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trialRichard W Laing, Hynek Mergental, Christina Yap, et al.
Plos Biology|June 8, 2023
Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasomeBrian V Tsu, Rimjhim Agarwal, Nandan S Gokhale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Addition of dendritic cell vaccination to conditioning cyclophosphamide and chemoembolisation in patients with hepatocellular carcinoma: the ImmunoTACE trialYuk Ting Ma, Jianmin Zuo, Amanda Kirkham, et al.
The Lancet. Oncology|March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Pageof 9